Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.

Spruance SL, Tyring SK, DeGregorio B, Miller C, Beutner K.

Arch Intern Med. 1996 Aug 12-26;156(15):1729-35.

PMID:
8694673
2.

Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans.

Soul-Lawton J, Seaber E, On N, Wootton R, Rolan P, Posner J.

Antimicrob Agents Chemother. 1995 Dec;39(12):2759-64.

3.
4.

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers.

Weller S, Blum MR, Doucette M, Burnette T, Cederberg DM, de Miranda P, Smiley ML.

Clin Pharmacol Ther. 1993 Dec;54(6):595-605.

PMID:
8275615
5.

Safety of acyclovir: a summary of the first 10 years experience.

Tilson HH, Engle CR, Andrews EB.

J Med Virol. 1993;Suppl 1:67-73.

PMID:
8245895
6.

Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Wagstaff AJ, Faulds D, Goa KL.

Drugs. 1994 Jan;47(1):153-205. Review.

PMID:
7510619
7.

Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults.

Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ.

Antimicrob Agents Chemother. 1995 Jul;39(7):1546-53.

8.
9.

A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection.

Douglas JM, Critchlow C, Benedetti J, Mertz GJ, Connor JD, Hintz MA, Fahnlander A, Remington M, Winter C, Corey L.

N Engl J Med. 1984 Jun 14;310(24):1551-6.

PMID:
6328298
10.

Oral acyclovir for episodic treatment of recurrent genital herpes. Efficacy and safety.

Goldberg LH, Kaufman R, Conant MA, Sperber J, Allen ML, Illeman M, Chapman S.

J Am Acad Dermatol. 1986 Aug;15(2 Pt 1):256-64.

PMID:
3745529
11.

Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial.

Mertz GJ, Jones CC, Mills J, Fife KH, Lemon SM, Stapleton JT, Hill EL, Davis LG.

JAMA. 1988 Jul 8;260(2):201-6.

PMID:
3290517
12.

Therapy of herpes zoster with oral acyclovir.

Huff JC, Bean B, Balfour HH Jr, Laskin OL, Connor JD, Corey L, Bryson YJ, McGuirt P.

Am J Med. 1988 Aug 29;85(2A):84-9.

PMID:
3044099
13.

Efficacy of oral acyclovir treatment of acute herpes zoster.

Wood MJ, Ogan PH, McKendrick MW, Care CD, McGill JI, Webb EM.

Am J Med. 1988 Aug 29;85(2A):79-83.

PMID:
3044098
15.

Acyclovir suppression of frequently recurring genital herpes. Efficacy and diminishing need during successive years of treatment.

Straus SE, Croen KD, Sawyer MH, Freifeld AG, Felser JM, Dale JK, Smith HA, Hallahan C, Lehrman SN.

JAMA. 1988 Oct 21;260(15):2227-30.

PMID:
2845160
16.

Oral acyclovir suppressive therapy in severe recurrent genital herpes. A double-blind, placebo-controlled cross-over study.

Kroon S, Petersen CS, Andersen LP, Rasmussen LP, Vestergaard BF.

Dan Med Bull. 1989 Jun;36(3):298-300.

PMID:
2666040
17.

Oral acyclovir in the treatment of herpes zoster in general practice.

Morton P, Thomson AN.

N Z Med J. 1989 Mar 8;102(863):93-5.

PMID:
2648213
18.

A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States.

Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB.

N Engl J Med. 1989 Jul 6;321(1):7-12.

PMID:
2543928
19.

Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world.

Nahmias AJ, Lee FK, Beckman-Nahmias S.

Scand J Infect Dis Suppl. 1990;69:19-36. Review.

PMID:
2175939
20.

The effect of prescribed daily dose frequency on patient medication compliance.

Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR.

Arch Intern Med. 1990 Sep;150(9):1881-4.

PMID:
2102668

Supplemental Content

Support Center